Gilead Sciences (United States)
In research, Gilead Sciences (United States) stands highest in Health Sciences (#616 of 9,902 worldwide), Medicine (#674 of 8,541 worldwide) and Infectious Diseases (#76 of 421 worldwide), 2022-now. Relative to its size it is most specialised in Hepatology, Infectious Diseases and Statistics and Probability (Hepatology is 26.9× its share of world research).
- World rank, 2022-now
- #2,129 of 22,385 · #1,584 all time
- Rank in United States
- #396 of 3,332
- Research works
- 2.1k ▲ 44% vs 2018-21
- Citations
- 81k 38.3 per fractional work
- Top-10% rate
- 15.0% all institutions 10.0%
- vs its own fields
- 1.16× 1.00× is exactly expected
- Open access
- 47% world 40%
- International
- 28% world 18%
What is Gilead Sciences (United States) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #616 of 9,902 | 17.9% | 320 | #451 | |
| MedicineField | #674 of 8,541 | 18.1% | 309 | #506 | |
| Infectious DiseasesSubfield | #76 of 421 | 24.5% | 76 | #53 | |
| Life SciencesDomain | #1,268 of 6,403 | 14.5% | 106 | #1235 |
Each strip is that field's whole ranked pool, with the notch where Gilead Sciences (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Health Sciences#451 #616
- Medicine#506 #674
- Infectious Diseases#53 #76
- Life Sciences#1,235 #1,268
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Which fields of science does Gilead Sciences (United States) work in?
In 2022-now, 63% of research at Gilead Sciences (United States) is in Health Sciences, 21% in Life Sciences. Its largest fields are Medicine (61%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (7%). It does 2.7× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers
- Health Sciences36663.3%
- Medicine35361.1%
- Health Professions101.8%
- Veterinary10.3%
- Nursing00.1%
- Dentistry00.0%
- Life Sciences12421.4%
- Physical Sciences5910.3%
- Mathematics233.9%
- Chemistry142.5%
- Computer Science91.5%
- Engineering61.1%
- Materials Science40.6%
- Environmental Science30.6%
- Chemical Engineering00.0%
- Physics and Astronomy00.0%
- Energy00.0%
- Earth and Planetary Sciences00.0%
- Social Sciences295.0%
What does Gilead Sciences (United States) specialise in?
Where its research is concentrated relative to its size: Hepatology takes 26.9× the share of its output that it takes of world research.
- HepatologySubfield · 29.9 works27×
- Infectious DiseasesSubfield · 90.6 works23×
- Statistics and ProbabilitySubfield · 22.3 works18×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.3×. Every wedge is a field page.
All 26 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics9.31×19 works
- Immunology and Microbiology7.08×41 works
- Mathematics3.35×23 works
- Medicine3.18×353 works
- Biochemistry, Genetics and Molecular Biology1.90×59 works
- Veterinary1.87×2 works
- Chemistry1.59×14 works
- Economics, Econometrics and Finance1.08×13 works
- Decision Sciences1.03×6 works
- Health Professions0.67×10 works
- Neuroscience0.19×2 works
- Computer Science0.19×9 works
- Materials Science0.17×4 works
- Nursing0.17×0 works
- Chemical Engineering0.13×0 works
- Agricultural and Biological Sciences0.12×3 works
- Psychology0.12×2 works
- Environmental Science0.11×3 works
- Business, Management and Accounting0.11×2 works
- Arts and Humanities0.09×1 works
- Engineering0.07×6 works
- Dentistry0.07×0 works
- Social Sciences0.06×4 works
- Earth and Planetary Sciences0.01×0 works
- Energy0.01×0 works
- Physics and Astronomy0.01×0 works
- Pharmacology, Toxicology and Pharmaceutics 9.3×
- Immunology and Microbiology 7.1×
- Mathematics 3.4×
- Medicine 3.2×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Veterinary 1.9×
- Chemistry 1.6×
- Economics, Econometrics and Finance 1.1×
- Decision Sciences 1.0×
- Health Professions 0.7×
- Neuroscience 0.2×
- Computer Science 0.2×
- Materials Science 0.2×
- Nursing 0.2×
- Chemical Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Psychology 0.1×
- Environmental Science 0.1×
- Business, Management and Accounting 0.1×
- Arts and Humanities 0.1×
- Engineering 0.1×
- Dentistry 0.1×
- Social Sciences 0.1×
- Earth and Planetary Sciences 0.0×
- Energy 0.0×
- Physics and Astronomy 0.0×
Who are the top researchers at Gilead Sciences (United States)?
Ranked on the quality score, G. Mani Subramanian, Andrew Cheng and Diana M. Brainard lead among researchers whose main affiliation is Gilead Sciences (United States).
- 1
G. Mani Subramanian
United States · #26,859 worldwide 26k citations · 217 works
- 2
Andrew Cheng
United States · #35,642 worldwide 11k citations · 118 works
- 3
Diana M. Brainard
United States · #45,990 worldwide 27k citations · 303 works
- 4
Tomáš Cihlář
United States · #47,129 worldwide 23k citations · 231 works
- 5
Lauri J. Diehl
United States · #48,113 worldwide 8.9k citations · 124 works
- 6
Hadas Dvory‐Sobol
United States · #63,897 worldwide 11k citations · 144 works
- 7
James F. Rooney
United States · #65,425 worldwide 24k citations · 213 works
- 8
Richard W. Wagner
United States · #66,810 worldwide 11k citations · 108 works
- 9
Cynthia C Brinson
United States · #73,697 worldwide 5.2k citations · 74 works
- 10
Phillip S. Pang
United States · #73,744 worldwide 11k citations · 89 works
Which keywords describe research at Gilead Sciences (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Antiretroviral Therapy, Immune Response, Epidemiology, HIV Infection, Vaccine, Antiviral Therapy, Hepatotoxicity and Drug Resistance.
- Thrombosis
- Chronic Hepatitis B
- Global Burden
- neurocognitive disorders
- Immune Activation
- Hepatitis C Virus
- Biomarkers
- ACE2 Receptor
- Pandemic
- Insulin Resistance
- Treatment
- Stigma and Discrimination
- Viral Load
- Mortality Rates
- Integrase Inhibitors
- Liver Disease
- Hepatotoxicity
- Antiviral Therapy
- HIV Infection
- Immune Response
- Antiretroviral Therapy
- Epidemiology
- Vaccine
- Inflammation
- Drug Resistance
- Adverse Effects
- Nucleoside Analogues
- HIV Transmission
- Preexposure Prophylaxis
- Hepatocellular Carcinoma
- Genetic Variation
- HIV
- SARS-CoV-2
- Antibodies
- Chemotherapy
- Ribavirin
- AIDS
- Pathogenesis
- Immunity
- Hepatitis B Virus
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Antiretroviral Therapy94▲ 99×6 topics
- Immune Response73▲ 22×16 topics
- Epidemiology73▲ 3.2×64 topics
- HIV Infection45▲ 75×3 topics
- Vaccine39▲ 17×11 topics
- Antiviral Therapy36▲ 66×3 topics
- Inflammation36▲ 3.0×52 topics
- Hepatotoxicity36▲ 127×2 topics
- Drug Resistance34▲ 20×6 topics
- Liver Disease34▲ 65×3 topics
- Adverse Effects32▲ 120×2 topics
- Integrase Inhibitors32▲ 263×1 topic
- Nucleoside Analogues32▲ 263×1 topic
- Mortality Rates30▲ 54×2 topics
- HIV Transmission29▲ 67×2 topics
- Viral Load29▲ 65×2 topics
- Preexposure Prophylaxis28▲ 100×1 topic
- Stigma and Discrimination28▲ 100×1 topic
- Hepatocellular Carcinoma28▲ 24×3 topics
- Treatment28▲ 3.9×24 topics
- Genetic Variation27▲ 21×5 topics
- Insulin Resistance27▲ 10×7 topics
- HIV26▲ 53×4 topics
- Pandemic24▲ 4.2×7 topics
- SARS-CoV-223▲ 13×4 topics
- ACE2 Receptor22▲ 17×2 topics
- Antibodies20▲ 60×2 topics
- Biomarkers19▲ 4.8×14 topics
- Chemotherapy19▲ 4.7×18 topics
- Hepatitis C Virus19▲ 99×1 topic
- Ribavirin19▲ 99×1 topic
- Immune Activation18▲ 40×2 topics
- AIDS18▲ 124×1 topic
- neurocognitive disorders18▲ 124×1 topic
- Pathogenesis18▲ 6.0×15 topics
- Global Burden16▲ 5.2×9 topics
- Immunity16▲ 6.9×8 topics
- Chronic Hepatitis B15▲ 77×1 topic
- Hepatitis B Virus15▲ 77×1 topic
- Thrombosis14▲ 8.8×7 topics
Which research topics does Gilead Sciences (United States) publish most on?
By volume in 2022-now: HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Hepatitis C virus research and HIV Research and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 HIV/AIDS drug development and treatment Infectious Diseases 32 works
- 2 HIV/AIDS Research and Interventions Infectious Diseases 28 works
- 3 Hepatitis C virus research Hepatology 19 works
- 4 HIV Research and Treatment Virology 18 works
- 5 Hepatitis B Virus Studies Epidemiology 15 works
- 6 HIV-related health complications and treatments Emergency Medicine 13 works
- 7 Liver Disease Diagnosis and Treatment Epidemiology 13 works
- 8 COVID-19 Clinical Research Studies Infectious Diseases 12 works
- 9 Drug Transport and Resistance Mechanisms Oncology 11 works
- 10 SARS-CoV-2 and COVID-19 Research Infectious Diseases 9 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Gilead Sciences (United States)'s research output changed?
Output in 2022-2025 was 44% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Gilead Sciences (United States) as a percentage of every work published that year, 0.0021% in 2024.
Fractional works of Gilead Sciences (United States) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 28.7% in 1995.
Other research institutions in Foster City
- Visa (United States)
- SciClone Pharmaceuticals (United States)
- Interdisciplinary Dental Education Academy
- Notable Labs (United States)
- TeraRecon (United States)
- Guidewire (United States)
- Apollomics (United States)
- Active Spectrum (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Gilead Sciences (United States). Posts are plain text and can be reported.
